• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于选择性研究SARS-CoV-2反应性中央记忆T细胞的培养ELISpot/荧光斑点技术的优化

Optimisation of the cultured ELISpot/Fluorospot technique for the selective investigation of SARS-CoV-2 reactive central memory T cells.

作者信息

Jerome Jack R, Wilson Kirsty L, Fialho Joshuah, Goodchild Georgia, Prakash Monica D, McLeod Charlie, Richmond Peter C, Apostolopoulos Vasso, Flanagan Katie L, Plebanski Magdalena

机构信息

School of Health and Biomedical Science, Royal Melbourne Institute of Technology University, Melbourne, VIC, Australia.

Accelerator for Translational Research in Clinical Trials (ATRACT) Centre, School of Health and Biomedical Sciences, Royal Melbourne Institute of Technology University, Melbourne, VIC, Australia.

出版信息

Front Immunol. 2025 Apr 15;16:1547220. doi: 10.3389/fimmu.2025.1547220. eCollection 2025.

DOI:10.3389/fimmu.2025.1547220
PMID:40303392
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12037488/
Abstract

INTRODUCTION

This study presents an optimised cultured ELISpot protocol for detecting central memory T-cell interferon gamma (IFNγ) responses against SARS-CoV-2 peptides following an initial priming with either peptides, or whole spike protein.

METHODS

Key variations optimised include the culture length, timing of exogenous survival signals (IL-2), and endpoint analysis modality and cell density to enhance assay sensitivity without compromising specificity for central memory T-cell IFNγ recall responses to cognate antigen.

RESULTS

We noted a culture duration of 10 days, combined with a delayed IL-2 administration on day 5 to enhance assay sensitivity while maintaining response specificity towards cognate antigen when compared with shorter culture periods or earlier exogenous survival signal provision. With regards to lower-frequency T-cell interactions, as we observed with our donor SARS-CoV-2 epitope responses, our findings suggest Fluorospot to be preferable to the chromogenic ELISpot modality, and an immediate cell washing after culture collection to better facilitate cognate antigen responses. Fluorospot enabled a higher cell density while minimising the generation of visual artefacts, meanwhile immediate cell washing was critical for improving endpoint assay sensitivity. CCR7+ cell depletion was used to demonstrate our optimised protocol to selectively demonstrate central memory T-cell responses. Lastly, we provide evidence for the capacity of our assay to delineate individual responding peptides following peptide pool priming, and to explore cross-reactivity between viral variant peptides.

CONCLUSION

This work advances the methodology for investigating T-cell immunity, particularly in the context of SARS-CoV-2, and emphasises the balance between enhancing specific cognate central memory responses while limiting non-specific activation.

摘要

引言

本研究提出了一种优化的培养ELISpot方案,用于检测在用肽或全长刺突蛋白进行初次致敏后,针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)肽的中枢记忆T细胞干扰素γ(IFNγ)反应。

方法

优化的关键变量包括培养时长、外源性存活信号(白细胞介素-2,IL-2)的添加时间、终点分析方式和细胞密度,以提高检测灵敏度,同时不影响中枢记忆T细胞对同源抗原的IFNγ回忆反应的特异性。

结果

我们发现培养持续10天,结合在第5天延迟给予IL-2,与较短的培养期或更早提供外源性存活信号相比,可提高检测灵敏度,同时保持对同源抗原的反应特异性。对于低频T细胞相互作用,正如我们在供体SARS-CoV-2表位反应中观察到的那样,我们的研究结果表明荧光斑点法比显色ELISpot法更可取,并且在培养物收集后立即进行细胞洗涤,以更好地促进同源抗原反应。荧光斑点法能够实现更高的细胞密度,同时最大限度地减少视觉假象的产生,与此同时,立即进行细胞洗涤对于提高终点检测灵敏度至关重要。使用CCR7+细胞耗竭来证明我们的优化方案能够选择性地显示中枢记忆T细胞反应。最后,我们提供证据表明我们的检测方法能够在肽池致敏后描绘出个体反应肽,并探索病毒变异肽之间的交叉反应性。

结论

这项工作改进了研究T细胞免疫的方法,特别是在SARS-CoV-2的背景下,并强调了在增强特异性同源中枢记忆反应的同时限制非特异性激活之间的平衡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/81b805c108f2/fimmu-16-1547220-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/39a9b3758a5c/fimmu-16-1547220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/d55108275cf7/fimmu-16-1547220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/aeb0128a6eef/fimmu-16-1547220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/bffe4df2e52d/fimmu-16-1547220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/c1e335438623/fimmu-16-1547220-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/2e22c9dddb0f/fimmu-16-1547220-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/5beabf588be3/fimmu-16-1547220-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/365b5e3d52a5/fimmu-16-1547220-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/81b805c108f2/fimmu-16-1547220-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/39a9b3758a5c/fimmu-16-1547220-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/d55108275cf7/fimmu-16-1547220-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/aeb0128a6eef/fimmu-16-1547220-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/bffe4df2e52d/fimmu-16-1547220-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/c1e335438623/fimmu-16-1547220-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/2e22c9dddb0f/fimmu-16-1547220-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/5beabf588be3/fimmu-16-1547220-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/365b5e3d52a5/fimmu-16-1547220-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6775/12037488/81b805c108f2/fimmu-16-1547220-g009.jpg

相似文献

1
Optimisation of the cultured ELISpot/Fluorospot technique for the selective investigation of SARS-CoV-2 reactive central memory T cells.用于选择性研究SARS-CoV-2反应性中央记忆T细胞的培养ELISpot/荧光斑点技术的优化
Front Immunol. 2025 Apr 15;16:1547220. doi: 10.3389/fimmu.2025.1547220. eCollection 2025.
2
Strategies to determine positive anti-SARS-CoV-2 memory T lymphocyte response during the evolution of an epidemic.在疫情演变过程中确定 SARS-CoV-2 记忆 T 淋巴细胞阳性反应的策略。
J Immunol Methods. 2024 Aug;531:113712. doi: 10.1016/j.jim.2024.113712. Epub 2024 Jun 19.
3
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.在 COVID-19 康复者中鉴定出的 SARS-CoV-2 特异性记忆 T 细胞表位。
Virus Res. 2021 Oct 15;304:198508. doi: 10.1016/j.virusres.2021.198508. Epub 2021 Jul 27.
4
Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.解析T细胞对SARS-CoV-2的反应:特异性与偶然性及同源交叉反应性
Front Immunol. 2021 May 28;12:635942. doi: 10.3389/fimmu.2021.635942. eCollection 2021.
5
Detection of IFNγ-Secreting CD4 and CD8 Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2.检测外周血单个核细胞经活 SARS-CoV-2 刺激后 COVID-19 恢复期患者 IFNγ 分泌的 CD4 和 CD8 记忆 T 细胞。
Viruses. 2021 Jul 29;13(8):1490. doi: 10.3390/v13081490.
6
T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern.接种抗 COVID-19 BNT162b2 疫苗后,T 细胞的反应仍然可以针对关注的 SARS-CoV-2 奥密克戎 B.1.1.529 变体。
Viruses. 2022 Feb 8;14(2):347. doi: 10.3390/v14020347.
7
Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19.广泛靶向 SARS-CoV-2 的特异性 CD4+ T 细胞反应包括急性和已解决的 COVID-19 患者中经常检测到的膜和核蛋白内的肽特异性。
PLoS Pathog. 2021 Sep 16;17(9):e1009842. doi: 10.1371/journal.ppat.1009842. eCollection 2021 Sep.
8
Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.破伤风白喉疫苗可激发对 SARS-CoV-2 具有交叉反应性的 T 细胞。
Front Immunol. 2024 Jul 18;15:1425374. doi: 10.3389/fimmu.2024.1425374. eCollection 2024.
9
Validation of an IFNγ/IL2 FluoroSpot assay for clinical trial monitoring.用于临床试验监测的IFNγ/IL2荧光斑点试验的验证
J Transl Med. 2016 Jun 14;14(1):175. doi: 10.1186/s12967-016-0932-7.
10
Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients.细胞和体液免疫原性针对 SARS-CoV-2 接种或感染与成年异基因造血细胞移植受者的 T 和 B 淋巴细胞记忆表型相关。
Int J Hematol. 2024 Aug;120(2):229-240. doi: 10.1007/s12185-024-03802-3. Epub 2024 Jun 6.

本文引用的文献

1
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic.新冠疫情期间严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的表型演变
Nat Microbiol. 2025 Jan;10(1):77-93. doi: 10.1038/s41564-024-01878-5. Epub 2025 Jan 3.
2
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.利用肯尼亚两个健康人口监测系统的样本评估人群对SARS-CoV-2变体EG.5.1、FY.4、BA.2.86、JN.1、JN.1.4和KP.3.1.1的免疫力。
BMC Infect Dis. 2024 Dec 28;24(1):1474. doi: 10.1186/s12879-024-10367-3.
3
Cross-protection and cross-neutralization capacity of ancestral and VOC-matched SARS-CoV-2 adenoviral vector-based vaccines.
基于祖先株和VOC匹配株的SARS-CoV-2腺病毒载体疫苗的交叉保护和交叉中和能力。
NPJ Vaccines. 2023 Oct 4;8(1):149. doi: 10.1038/s41541-023-00737-4.
4
Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19.COVID-19 重症患者的 SARS-CoV-2 特异性 T 细胞反应受损。
Front Immunol. 2023 Apr 17;14:1046639. doi: 10.3389/fimmu.2023.1046639. eCollection 2023.
5
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.SARS-CoV-2 变异株的进化:对免疫逃逸、疫苗接种、治疗和诊断策略的影响。
Viruses. 2023 Apr 10;15(4):944. doi: 10.3390/v15040944.
6
HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes.HLA 变体对呈现具有特定分子功能的蛋白质有不同的偏好,这些偏好在常见的单倍型中得到补充。
Front Immunol. 2022 Dec 20;13:1067463. doi: 10.3389/fimmu.2022.1067463. eCollection 2022.
7
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4 T cell recognition.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的突变会损害表位特异性CD4 T细胞识别。
Nat Immunol. 2022 Dec;23(12):1726-1734. doi: 10.1038/s41590-022-01351-7. Epub 2022 Dec 1.
8
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.Tfh 细胞和生发中心是 ChAdOx1 nCoV-19 疫苗接种后记忆 B 细胞形成和体液免疫所必需的。
Cell Rep Med. 2022 Dec 20;3(12):100845. doi: 10.1016/j.xcrm.2022.100845. Epub 2022 Nov 15.
9
Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.低基线 IFN-γ 反应可预测 COVID-19 患者的住院情况。
Front Immunol. 2022 Sep 26;13:953502. doi: 10.3389/fimmu.2022.953502. eCollection 2022.
10
Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy.优势表位由常见 HLA 等位基因呈递,允许广泛使用储存的 CMVpp65 T 细胞进行过继治疗。
Blood Adv. 2022 Aug 23;6(16):4859-4872. doi: 10.1182/bloodadvances.2022007005.